Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/24/20 → 09/23/22 |
Funding
- US Food and Drug Administration: $527,735.00
Evaluating LRT for Post-Market Surveillance of Adverse Events
- Markatou, Marianthi (PI)
- Talal, Andrew (CoI)
Project: Research